Amandine Lenglet has over 15 years of experience in marketing and sales roles in the pharmaceutical industry, with a focus on rare diseases. She has successfully led numerous product launches globally and locally in Europe and Asia, leveraging her expertise in building commercial strategies and leading cross-functional teams. With a Doctor of Pharmacy degree from Université Paris Sud (Paris XI), she has specialized in launch, marketing, and commercial strategies for biotechnology, rare diseases, and orphan drugs in the nephrology, hematology, endocrinology, metabolic diseases, immunology, and complement fields. She has held various leadership positions at Alexion Pharmaceuticals, Inc., including Global aHUS lead and Strategic Marketing Director, EMEA Canada strategy, and Regional Account Manager Switzerland. Amandine has also attended the Open Program at IMD Business School and has a Master's degree from ESCP Europe. Her areas of expertise include life cycle management, key account management, KOL management, medical education, patient support programs, diagnostic strategies, and disease awareness campaigns/patient finding initiatives.